From antibodies to AI: what is patentable in the US and Europe?
In this webinar for university knowledge exchange practitioners, patent attorneys and senior associates Edward Rainsford and Parminder Lally discussed what can, and cannot, be patented at the European Patent Office (EPO) and the US Patent and Trademark Office (USPTO).
Don’t delay filing your UK divisional patent applications
In this article, senior associate and patent attorney Parminder Lally, and trainee patent attorney Debora Dorn, provide a summary of the new practice regarding UK divisional patent applications, that will come into effect on 1 May 2023.
Femtech: The rise of female-focused innovation
This article discusses examples of femtech innovations that have been patented in recent years.
Can you patent digital assistant technology?
In this article, we look at a patent application for virtual assistant technology, and provide advice on whether this sort of software-based innovation is patentable.
Introduction to intellectual property: myths and misconceptions
Intellectual property can help a business protect its innovation and brand, while making it more attractive to investors. In this webinar, Aurora’s Joshua Dent discusses the basics of intellectual property (IP) with patent attorney and senior associate Parminder Lally and trade mark attorney Daniel Bailey. They bust common IP myths, explain why business owners should develop an IP strategy at an early […]
Let’s ask artificial intelligence: how good is your grammar?
Senior associate Parminder Lally looks at artificial intelligence-based grammar tools, and provide advice on whether this type of technology is patentable.
Billion Dollar Code: how start-ups can win the Quids Game
Parminder Lally’s article shows start-ups how to avoid the mistakes made by the start-up in Netflix’s The Billion Dollar Code.
Is it really easier to get your software patents granted in the U.S.?
In this article, we compare the requirements to obtain patents in the U.S. and Europe in the context of computer-implemented inventions such as simulation methods and artificial intelligence (AI).
Is it worth patenting your AI tools for drug discovery?
Often, when the AI identifies a drug, and experiments confirm it is useful for the intended purpose, the drug can be patented. But what about the AI itself – can the AI be protected by patents, and should you try to?
Intellectual property for start-ups in a post-COVID world: part five – managing know-how and trade secrets
This series of articles explores the effect of COVID-19-related disruption on start-ups’ management and monetisation of intellectual property (IP), giving practical guidance to start-ups to improve and preserve their position for the future. Part one of our series focuses on strategic considerations for managing patents during this unprecedented time Part two outlines strategies start-ups can […]
